Literature DB >> 6352285

A lipopolysaccharide and concanavalin A induce variations of serotonin levels in mouse tissues.

Y Endo.   

Abstract

The administration of an Escherichia coli lipopolysaccharide (LPS), or an endotoxin into mice produced a variation in tissue serotonin (5HT) levels within 4.5 h. 5HT levels in the kidney and lung were decreased by the higher doses of LPS, but those in the liver and spleen were increased even by lower doses of the agent. The increase in liver 5HT was most marked. Such variations in 5HT levels were also produced by the administration of concanavalin A. In vitro experiments using extracts from livers of LPS-treated and non-treated mice indicated that there was no difference in the 5HT formation from 5-hydroxytryptophan between the two groups, but that 5HT formation from tryptophan was higher in the LPS-treated mice. The LPS-induced 5HT increase in liver was suppressed by p-chlorophenylalanine (an inhibitor of tryptophan hydroxylase), actinomycin D, cycloheximide and dexamethasone, but not by Ro 4-4602 (an inhibitor of aromatic amino acid decarboxylase), pargyline (an inhibitor of monoamine oxidase) and indomethacin. A possible mechanism of the 5HT increase in the liver is discussed on the basis of these results.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352285     DOI: 10.1016/0014-2999(83)90175-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  The effect of lipopolysaccharide, interleukin-1 and tumour necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse.

Authors:  Y Endo; M Nakamura
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

2.  Biphasic, organ-specific, and strain-specific accumulation of platelets induced in mice by a lipopolysaccharide from Escherichia coli and its possible involvement in shock.

Authors:  M Shibazaki; M Nakamura; Y Endo
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

3.  Induction of hypoglycaemia and accumulation of 5-hydroxytryptamine in the liver after the injection of mitogenic substances into mice.

Authors:  Y Endo
Journal:  Br J Pharmacol       Date:  1984-04       Impact factor: 8.739

4.  Evidence that the accumulation of 5-hydroxytryptamine in the liver but not in the brain may cause the hypoglycaemia induced by 5-hydroxytryptophan.

Authors:  Y Endo
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

5.  Suppression and potentiation of 5-hydroxytryptophan-induced hypoglycaemia by alpha-monofluoromethyldopa: correlation with the accumulation of 5-hydroxytryptamine in the liver.

Authors:  Y Endo
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.